1-13 of 13
rivaroxaban
Close
Sort by
Journal Articles

Is there a role for low-dose DOACs as prophylaxis?

Alexander T. Cohen, Beverley J. Hunt
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 187–193.
https://doi.org/10.1182/hematology.2019000026
Published: 2019
Journal Articles

Evidence-Based Minireview: Mortality and thrombosis in patients receiving prothrombin complex concentrates or andexanet alfa for the management of direct oral factor Xa inhibitor–associated major bleeding

Miriam Kimpton, Deborah M. Siegal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 204–208.
https://doi.org/10.1182/hematology.2019000074
Published: 2019
Journal Articles

Drug-drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions

Sara R. Vazquez
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 339–347.
https://doi.org/10.1182/asheducation-2018.1.339
Published: 2018
Journal Articles

Reversal of direct oral anticoagulants: a practical approach

Andrew W. Shih, Mark A. Crowther
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 612–619.
https://doi.org/10.1182/asheducation-2016.1.612
Published: 2016
Journal Articles

Monitoring and reversal of direct oral anticoagulants

Adam Cuker, Deborah Siegal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 117–124.
https://doi.org/10.1182/asheducation.V2015.1.117.3916182
Published: 2015
Journal Articles

Monitoring target-specific oral anticoagulants

Barbara A. Konkle
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 329–333.
https://doi.org/10.1182/asheducation-2014.1.329
Published: 2014
Journal Articles

What is the effect of rivaroxaban on routine coagulation tests?

Deborah M. Siegal, Barbara A. Konkle
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 334–336.
https://doi.org/10.1182/asheducation-2014.1.334
Published: 2014
Journal Articles

Reversing targeted oral anticoagulants

Maureane Hoffman, Dougald M. Monroe
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 518–523.
https://doi.org/10.1182/asheducation-2014.1.518
Published: 2014
Journal Articles

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders

Margaret V. Ragni
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 44–51.
https://doi.org/10.1182/asheducation-2013.1.44
Published: 2013
Journal Articles

Pros and cons of new oral anticoagulants

Kenneth A. Bauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 464–470.
https://doi.org/10.1182/asheducation-2013.1.464
Published: 2013
Journal Articles

Thrombosis in pregnancy: updates in diagnosis and management

Ian A. Greer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 203–207.
https://doi.org/10.1182/asheducation.V2012.1.203.3798262
Published: 2012
Journal Articles

Perioperative management of patients on chronic antithrombotic therapy

Thomas L. Ortel
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 529–535.
https://doi.org/10.1182/asheducation.V2012.1.529.3799663
Published: 2012
Journal Articles

New Issues in Oral Anticoagulants

Charles W. Francis
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 259–265.
https://doi.org/10.1182/asheducation-2008.1.259
Published: 2008